Case Study · Health & Healthcare

$151.1 Billion Annual Social Value Loss from Arthritis in Canada by 2055

A chronic-disease case assessed the long-run social value burden of arthritis in Canada.

Annual social value loss, 2055

$151.1 billion

Arthritis Society Canada · 2026

What the Work Shows

The report estimated a total annual burden of $142.4 billion in 2025, rising to $222.3 billion by 2055. Within that total, annual social value loss rises from $96.5 billion to $151.1 billion.

The analysis compares scenarios with and without arthritis and connects healthcare use, employment, private costs, disability and wellbeing within one national framework.

View the public CANCEA source →

Why It Matters

Decision-makers can use this kind of evidence to understand both the scale of an outcome and who experiences it — a stronger basis for comparing options, communicating value and testing whether an intervention improves people's lives.

Your decision

Have a Similar Question?

Tell us what you need to compare, prove or understand. We will tell you what evidence is possible.

Start a Conversation